| Revenue growth | Value |
|---|---|
| 3Y CAGR | +34% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +227% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,930.50 -47.70 (0.96%) | 22,759.95 | 30.96 | 5.42 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,524.00 -36.80 (1.44%) | 19,444.55 | 28.68 | 5.42 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,305.00 -110.50 (1.49%) | 18,526.25 | 109.22 | 21.23 | ||
Natco PharmaNATCOPHARM | ₹886.20 +3.80 (0.43%) | 15,806.45 | 13.81 | 1.71 |